Crowdly
Add to Chrome
Integrated Pharmacotherapy I
Looking for Integrated Pharmacotherapy I test answers and solutions? Browse our comprehensive collection of verified answers for Integrated Pharmacotherapy I at www.gmu-elc.com.
Get instant access to accurate answers and detailed explanations for your course questions. Our community-driven platform helps students succeed!
A 55-year-old man with type 2 diabetes presents with a BP of 138/86 mmHg on two separate clinic visits. He has no history of ASCVD, CKD, or heart failure. Which of the following is the most appropriate management step?
What is the key structural feature of
cholestyramine that allows it to bind bile acids?
Which structural feature of irbesartan (shown below) improves its hydrophobic interaction with the angiotensin II receptor?
A 65-year-old patient is prescribed captopril for hypertension. After a few weeks of treatment, the patient develops a persistent dry cough. What is the most likely reason for the dry cough in this patient taking captopril?
A 58-year-old man presents for follow-up a week after an acute myocardial infarction. His LDL cholesterol is 95 mg/dL. He is otherwise stable with no contraindications to statins. Which is the most appropriate statin therapy for this patient?
Which of the following factors directly affects total peripheral resistance rather than cardiac output?
What is the primary
reason why statins with a lactone ring, such as simvastatin (shown below), are
considered prodrugs?
A 62-year-old woman with long-standing hypertension and stage 3 chronic kidney disease (eGFR 45 mL/min/1.73m², proteinuria present) presents for follow-up. Which of the following antihypertensive class is the preferred initial choice?
Which of the
following structural changes in clonidine (shown below) reduces its basicity,
facilitating CNS penetration?
Which of the following is NOT a function of cholesterol in the human body?